A gene therapy designed to replace the missing protein that causes fragile X syndrome restored several disease-relevant ...
Within every muscle of every living species with a backbone, a protein called myosin tugs on a partner protein to generate a ...
Morning Overview on MSN
A gene-network study says existing drugs might be repurposed to slow human aging
Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.
6don MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
Gene signatures derived from genomic, transcriptomic, and immune profiling predict prognosis and response to immune ...
Morning Overview on MSN
A one-shot gene edit safely lowered cholesterol in its first human trial
A single infusion of an experimental gene-editing therapy called VERVE-102 lowered LDL cholesterol in people with dangerously high lipid levels, marking the first time in vivo base editing of the ...
A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map that details ...
GlobalData on MSN
Apertura and NIH institutes to test gene therapy for NPC1
The Ara Parseghian Medical Research Fund will provide financial backing for the multi-year research effort.
Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results